Furthermore, the administration of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) in order to correct neutropenia worsens the disease status, suggesting the role of neutrophils in SCD pathogenesis (45). The gene discussed is CSF2; the disease is neutropenia.